PunicalinCAS# 65995-64-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 65995-64-4 | SDF | Download SDF |
| PubChem ID | 5464368 | Appearance | Yellow crystalline |
| Formula | C34H22O22 | M.Wt | 782.52 |
| Type of Compound | Phenols | Storage | Desiccate at -20°C |
| Solubility | Soluble in methanol and water | ||
| SMILES | C1C2C(C(C(C(O2)O)O)O)OC(=O)C3=CC(=C(C(=C3C4=C(C(=C5C6=C4C(=O)OC7=C(C(=C(C8=C(C(=C(C=C8C(=O)O1)O)O)O)C(=C67)C(=O)O5)O)O)O)O)O)O)O | ||
| Standard InChIKey | IQHIEHIKNWLKFB-ITTSEVFZSA-N | ||
| Standard InChI | InChI=1S/C34H22O22/c35-6-1-4-9(19(39)17(6)37)11-15-13-14-16(33(50)56-28(13)23(43)21(11)41)12(22(42)24(44)29(14)55-32(15)49)10-5(2-7(36)18(38)20(10)40)31(48)54-27-8(3-52-30(4)47)53-34(51)26(46)25(27)45/h1-2,8,25-27,34-46,51H,3H2/t8-,25-,26-,27-,34-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Punicalin exerts anti-inflammatory, antioxidative, and anti-hepatotoxic activities, it shows inhibitory activity on HIV-1 reverse transcriptase in a dose-dependent manner, with an IC50 of 0.11 microg/ml (0.14 microM). |
| Targets | HIV | Immunology & Inflammation related |
| In vivo | Effects of punicalagin and punicalin on carrageenan-induced inflammation in rats.[Pubmed: 10592846]Am J Chin Med. 1999;27(3-4):371-6.Punicalagin and Punicalin were isolated from the leaves of Terminalia catappa L. Antioxidant and hepatoprotective activity of punicalagin and punicalin on carbon tetrachloride-induced liver damage in rats.[Pubmed: 9720629]J Pharm Pharmacol. 1998 Jul;50(7):789-94.Punicalagin and Punicalin, isolated from the leaves of Terminalia catappa L., are used to treat dermatitis and hepatitis. Both compounds have strong antioxidative activity. The antihepatotoxic activity of punicalagin and Punicalin on carbon tetrachloride (CCl4)-induced toxicity in the rat liver was evaluated. |
| Kinase Assay | Two ellagitannins from the leaves of Terminalia triflora with inhibitory activity on HIV-1 reverse transcriptase.[Pubmed: 15472920]Phytother Res. 2004 Aug;18(8):667-9.The bioassay- guided fractionation of the aqueous extract of Terminalia triflora leaves afforded Punicalin and 2-O-galloylPunicalin, isolated for the first time from this species. |
Punicalin Dilution Calculator
Punicalin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.2779 mL | 6.3896 mL | 12.7792 mL | 25.5585 mL | 31.9481 mL |
| 5 mM | 0.2556 mL | 1.2779 mL | 2.5558 mL | 5.1117 mL | 6.3896 mL |
| 10 mM | 0.1278 mL | 0.639 mL | 1.2779 mL | 2.5558 mL | 3.1948 mL |
| 50 mM | 0.0256 mL | 0.1278 mL | 0.2556 mL | 0.5112 mL | 0.639 mL |
| 100 mM | 0.0128 mL | 0.0639 mL | 0.1278 mL | 0.2556 mL | 0.3195 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Punicalagin
Catalog No.:BCN1037
CAS No.:65995-63-3
- Isogarciniaxanthone E
Catalog No.:BCN4205
CAS No.:659747-28-1
- Micranoic acid A
Catalog No.:BCN4204
CAS No.:659738-08-6
- AMG-517
Catalog No.:BCC1052
CAS No.:659730-32-2
- Esculentoside C
Catalog No.:BCN5012
CAS No.:65931-92-2
- Dienogest
Catalog No.:BCC4489
CAS No.:65928-58-7
- Danshenxinkun C
Catalog No.:BCN2471
CAS No.:65907-77-9
- Danshenxinkun B
Catalog No.:BCN2470
CAS No.:65907-76-8
- Danshenxinkun A
Catalog No.:BCN2469
CAS No.:65907-75-7
- Betaxolol
Catalog No.:BCC4342
CAS No.:659-18-7
- Tioconazole
Catalog No.:BCC4867
CAS No.:65899-73-2
- Daturabietatriene
Catalog No.:BCN4203
CAS No.:65894-41-9
- Uracil
Catalog No.:BCN4211
CAS No.:66-22-8
- Strophantidin
Catalog No.:BCC8255
CAS No.:66-28-4
- Dicoumarol
Catalog No.:BCC9225
CAS No.:66-76-2
- Cycloheximide
Catalog No.:BCC3653
CAS No.:66-81-9
- D-Glucosamine hydrochloride
Catalog No.:BCN5982
CAS No.:66-84-2
- Psoralen
Catalog No.:BCN4219
CAS No.:66-97-7
- H-Nva-OH
Catalog No.:BCC2643
CAS No.:6600-40-4
- Cirsimaritin
Catalog No.:BCN4206
CAS No.:6601-62-3
- 6-Demethoxytangeretin
Catalog No.:BCN3844
CAS No.:6601-66-7
- (5Z)-7-Oxozeaenol
Catalog No.:BCC7724
CAS No.:66018-38-0
- H-D-Arg(NO2)-OH
Catalog No.:BCC2871
CAS No.:66036-77-9
- Glycyrin
Catalog No.:BCN7681
CAS No.:66056-18-6
Two ellagitannins from the leaves of Terminalia triflora with inhibitory activity on HIV-1 reverse transcriptase.[Pubmed:15472920]
Phytother Res. 2004 Aug;18(8):667-9.
The bioassay- guided fractionation of the aqueous extract of Terminalia triflora leaves afforded Punicalin and 2-O-galloylPunicalin, isolated for the first time from this species. These compounds showed inhibitory activity on HIV-1 reverse transcriptase in a dose-dependent manner. Punicalin showed an IC(50) of 0.11 microg/ml (0.14 microM) and 2-O-galloylPunicalin an IC(50) of 0.10 microg/ml (0.11 microM).
Effects of punicalagin and punicalin on carrageenan-induced inflammation in rats.[Pubmed:10592846]
Am J Chin Med. 1999;27(3-4):371-6.
Punicalagin and Punicalin were isolated from the leaves of Terminalia catappa L. In this study, we evaluated the anti-inflammatory activity of punicalagin and Punicalin carrageenan-induced hind paw edema in rats. After evaluation of the anti-inflammatory effects, the edema rates were increased by carrageenan administration and reduced by drug treatment. After 4 hr of carrageenan administration, the best effect group was the punicalagin (10 mg/kg) treated group (inhibition rate was 58.15%), and the second was the punicalagin (5 mg/kg)-treated group (inhibition rate was 39.15%). However, even if the anti-inflammatory activity of punicalagin was the same as Punicalin at the 5 mg/kg dose, the inhibition effect from larger doses of punicalagin was increased, but there was a decrease with a larger dose of Punicalin. The data showed that both punicalagin and Punicalin exert anti-inflammatory activity, but treatment with larger doses of Punicalin may induce some cell damages.
Antioxidant and hepatoprotective activity of punicalagin and punicalin on carbon tetrachloride-induced liver damage in rats.[Pubmed:9720629]
J Pharm Pharmacol. 1998 Jul;50(7):789-94.
Punicalagin and Punicalin, isolated from the leaves of Terminalia catappa L., are used to treat dermatitis and hepatitis. Both compounds have strong antioxidative activity. The antihepatotoxic activity of punicalagin and Punicalin on carbon tetrachloride (CCl4)-induced toxicity in the rat liver was evaluated. Levels of serum glutamate-oxalate-transaminase and glutamate-pyruvate-trans-aminase were increased by administration of CCl4 and reduced by drug treatment. Histological changes around the liver central vein and oxidation damage induced by CCl4 also benefited from drug treatment. The results show that both punicalagin and Punicalin have anti-hepatotoxic activity but that the larger dose of Punicalin induced liver damage. Thus even if tannins have strong antioxidant activity at very small doses, treatment with a larger dose will induce cell damage.
